Advances in Rheumatology (Jul 2024)

Recommendations on cutaneous and hematological manifestations of Sjögren’s disease by the Brazilian Society of Rheumatology

  • Alisson Pugliesi,
  • Danielle Christinne Soares do Egypto,
  • Guilherme Duffles,
  • Diego Ustárroz Cantali,
  • Sandra Gofinet Pasoto,
  • Fabiola Reis Oliveira,
  • Valeria Valim,
  • Maria Lucia Lemos Lopes,
  • Samira Tatiyama Miyamoto,
  • Marilena Leal Mesquita Silvestre Fernandes,
  • Sonia Cristina de Magalhães Souza Fialho,
  • Aysa César Pinheiro,
  • Laura Caldas dos Santos,
  • Simone Appenzeller,
  • Sandra Lucia Euzébio Ribeiro,
  • Tatiana Nayara Libório-Kimura,
  • Maria Carmen Lopes Ferreira Silva Santos,
  • Juliana D´Agostino Gennari,
  • Roberta Pernanbuco,
  • Karina Gatz Capobiano,
  • Vinicius Tassoni Civile,
  • Ana Carolina Pereira Nunes Pinto,
  • César Ramos Rocha-Filho,
  • Aline Pereira da Rocha,
  • Virginia Fernandes Moça Trevisani

DOI
https://doi.org/10.1186/s42358-024-00391-x
Journal volume & issue
Vol. 64, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Sjogren’s disease (SjD) is an autoimmune disease that is characterized not only by the sicca symptoms it causes but also by its systemic nature, which is capable of several and not yet fully understood extraglandular manifestations. To gain a clearer understanding of these manifestations as well as a better practical approach, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of the extraglandular manifestations present in ESSDAI (EULAR Sjogren´s syndrome disease activity index), followed by a voting panel with recommendations for clinical practice. This publication is complementary to others already published and covers cutaneous and hematological manifestations, with prevalence data generated by a meta-analysis of 13 clinical or laboratory manifestations and 6 clinical management recommendations.